April 19 (SeeNews) - The Bulgarian competition authority said on Wednesday it was requested to evaluate a planned transaction under which UK-based Comet International Holding will fully acquire Bulgarian clinical research solutions provider Comac Medical and its subsidiaries.
The deal is expected to have no substantial impact on the relevant product-geographical markets worldwide, the Commission on Protection of Competition (CPC) said in a notice.
You can subscribe to our M&A newsletter here
Comet International, owned by Estonia-based investment fund EdgeCap Partners I Usaldusfond, is a newly established company with the purpose of acquiring Comac Medical. Neither Comet International nor EdgeCap Partners I are currently active on any market, the CPC said.
Founded in 1997, Comac Medical is a contract research organisation (CRO) and site management organisation (SMO) services provider operating across 28 European countries, the U.S. and Canada. The firm assists companies with all aspects of organising, conducting and monitoring clinical trials in Bulgaria and the region.